Thank you for your interest, please fill in the form for a quote or any other questions about a product or application area.

Name:

*Email:

*Repeat email:

Message:

Coming Soon

Tell me more

Recover low volumes of cryopreserved samples with the VIA Thaw SC2

VIA Thaw S2 automates the recovery of cryopreserved cell therapies contained in 2 mL screw cap vials. Based on dry conduction thawing, this bench-top instrument standardizes a critical step in the delivery of cell therapies with a simple, reproducible and traceable thawing process, overcoming common challenges associated with water bath thawing.



Available with my.Cryochain integration with the web-based platform enables thawing processes to be developed centrally, standardized between units and across sites and provides remote access to thaw records from all linked VIA Thaw SC2 units.



Automated, dry thawing with an accessible electronic record

Controlled thawing:

Protect your cell therapies by automating thawing to an exact endpoint.

Consistent results:

Standardize thawing with pre-set profiles, transmitted to all VIA Thaw units and lock to one profile for added reliability.

Convenient thawing:

Eliminate water-borne contamination risks and streamline processes with dry thawing technology.

Complete visibility:

Access digital thaw records from any web browser to inform and validate thawing processes.



CAUTION CONCERNING FORWARD-LOOKING STATEMENTS:

This information contains "forward-looking statements" – that is, statements related to future events that by their nature address matters that are, to different degrees, uncertain.

For details on the uncertainties that may cause our actual future results to be materially different than those expressed in our forward-looking statements, see http://www.ge.com/investor-relations/disclaimer-caution-concerning-forwardlooking-statements as well as our annual reports on Form 10-K and quarterly reports on Form 10-Q.

We do not undertake to update our forward-looking statements. This document also includes certain forward-looking projected financial information that is based on current estimates and forecasts. Actual results could differ materially. to total risk-weighted assets.

GE and GE monogram are trademarks of General Electric Company.

©2015 General Electric Company—All rights reserved. First published January 2015.

The VIA Freeze range, my.Cryochain and the VIA Thaw series are not medical devices and should not be used in diagnostic processes. Drug manufacturers & clinicians are responsible for obtaining the appropriate IND/BLA/NDA approvals for clinical applications.

GE Healthcare UK Limited, Amersham Place, Little Chalfont, Buckinghamshire, HP7 9NA, UK